Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence

scientific article published on 13 February 2008

Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/JCM.01938-07
P932PMC publication ID2292903
P698PubMed publication ID18272712

P50authorElizabeth StreicherQ30111637
Robin M. WarrenQ42425682
P2093author name stringP D van Helden
T C Victor
M Hanekom
H Albert
A Jordaan
E Hoosain
A A Falmer
A Trollip
O J Strauss
P2860cites workDetection of rifampicin-resistance mutations in Mycobacterium tuberculosisQ28248794
Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiologyQ29547284
Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodologyQ29614561
Characterization of spontaneous, In vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37RvQ33980958
Global dissemination of the Mycobacterium tuberculosis W-Beijing family strainsQ34469664
Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing familyQ34502921
The biological cost of mutational antibiotic resistance: any practical conclusions?Q34554396
Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic reviewQ34762099
A recently evolved sublineage of the Mycobacterium tuberculosis Beijing strain family is associated with an increased ability to spread and cause diseaseQ35784560
Beijing/W genotype Mycobacterium tuberculosis and drug resistanceQ36029451
Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa.Q36240511
Predominance of a single genotype of Mycobacterium tuberculosis in countries of east AsiaQ36526614
The competitive cost of antibiotic resistance in Mycobacterium tuberculosisQ40311130
Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutantsQ42550095
Molecular epidemiology and drug resistance of Mycobacterium tuberculosis isolates in the Archangel prison in Russia: predominance of the W-Beijing clone family.Q44564499
Phylogenetic reconstruction within Mycobacterium tuberculosis Beijing genotype in northwestern RussiaQ47409707
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectMycobacterium tuberculosisQ130971
P304page(s)1514-1516
P577publication date2008-02-13
P1433published inJournal of Clinical MicrobiologyQ4041880
P1476titleSpread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence
P478volume46

Reverse relations

cites work (P2860)
Q35890502A Novel Molecular Strategy for Surveillance of Multidrug Resistant Tuberculosis in High Burden Settings
Q41695565Acquisition of Rifampin Resistance in Pulmonary Tuberculosis
Q37455406Characterization of W-Beijing isolates of Mycobacterium tuberculosis from the Western Cape.
Q43622708Characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Sichuan in China
Q47139099Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa
Q37696851Compensation of fitness costs and reversibility of antibiotic resistance mutations
Q51532520Detecting drug-resistant tuberculosis: the importance of rapid testing.
Q37349855Doomsday postponed? Preventing and reversing epidemics of drug-resistant tuberculosis
Q36825946Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa
Q37026504Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa
Q28481689Estimating fitness by competition assays between drug susceptible and resistant Mycobacterium tuberculosis of predominant lineages in Mumbai, India
Q36172190Genetic determinants of drug-resistant tuberculosis among HIV-infected patients in Nigeria
Q30555347Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype
Q36070976Modeling the dynamic relationship between HIV and the risk of drug-resistant tuberculosis
Q35037192Models to understand the population-level impact of mixed strain M. tuberculosis infections
Q36173979Molecular Epidemiological Interpretation of the Epidemic of Extensively Drug-Resistant Tuberculosis in South Africa.
Q37915820Mycobacterium tuberculosis Beijing genotype: a template for success.
Q47581974Mycobacterium tuberculosis strains spreading in Hanoi, Vietnam: Beijing sublineages, genotypes, drug susceptibility patterns, and host factors
Q36932942Population structure analysis of the Mycobacterium tuberculosis Beijing family indicates an association between certain sublineages and multidrug resistance.
Q37374841Population structure dynamics of Mycobacterium tuberculosis Beijing strains during past decades in Japan
Q34101580Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa
Q28535594Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South Africa
Q36310070Proportion of multidrug-resistant tuberculosis in human immunodeficiency virus/mycobacterium tuberculosis co-infected patients in Korea
Q36558393Putative compensatory mutations in the rpoC gene of rifampin-resistant Mycobacterium tuberculosis are associated with ongoing transmission
Q36974201Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux
Q37065759Rifampin Resistance Mutations Are Associated with Broad Chemical Remodeling of Mycobacterium tuberculosis
Q26781111Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis
Q46071679Rv2629 191A/C nucleotide change is not associated with rifampicin resistance in Mycobacterium tuberculosis
Q48102085Signatures of Selection at Drug Resistance Loci in Mycobacterium tuberculosis.
Q30235074The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Q37683485The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?
Q33756724The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa
Q28081282The potential impact of coinfection on antimicrobial chemotherapy and drug resistance
Q34992863There is no correlation between sublineages and drug resistance of Mycobacterium tuberculosis Beijing/W lineage clinical isolates in Xinjiang, China
Q64134549Transmission of drug-resistant tuberculosis in HIV-endemic settings
Q42146421Whole genome sequence analysis of multidrug-resistant Mycobacterium tuberculosis Beijing isolates from an outbreak in Thailand

Search more.